CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
Chee Young Kim, Sang Hyuk Seo, Min Sung An, Kwang Hee Kim, Ki Beom Bae, Jin Won Hwang, Ji Hyun Kim, Bo Mi Kim, Mi Seon Kang, Min Kyung Oh, Kwan Hee Hong
Ann Coloproctol. 2015;31(3):92-97.   Published online June 30, 2015
DOI: https://doi.org/10.3393/ac.2015.31.3.92

Excel Download

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
Annals of Coloproctology. 2015;31(3):92   Crossref logo
Link1

Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy
Journal of Surgical Oncology. 2013;108(7):457-464   Crossref logo
Link1 Link2

ERCC1, Defective Mismatch Repair Status as Predictive Biomarker of Survival for Stage III Colon Cancer Patients Receiving Oxaliplatin Based Adjuvant Chemotherapy
Annals of Oncology. 2012;23:ix180   Crossref logo
Link1 Link2

Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients
Cancer Genetics. 2017;218-219:51-57   Crossref logo
Link1 Link2

Predictive value of ERCC1, ERCC2, and XRCC expression for patients with locally advanced or metastatic gastric cancer treated with neoadjuvant FOLFOX chemotherapy
European Journal of Surgical Oncology. 2017;43(11):2216   Crossref logo
Link1 Link2

Predictive value of ERCC1, ERCC2, and XRCC expression for patients with locally advanced or metastatic gastric cancer treated with neoadjuvant FOLFOX chemotherapy
European Journal of Surgical Oncology. 2018;44:S17   Crossref logo
Link1 Link2

Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy
Journal of Cancer Therapy. 2016;07(09):622-634   Crossref logo
Link1 Link2 Link3

ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy
British Journal of Cancer. 2013;108(6):1238-1244   Crossref logo
Link1 Link2 Link3

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Yearbook of Pulmonary Disease. 2008;2008:157-159   Crossref logo
Link1 Link2

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Yearbook of Oncology. 2008;2008:158-160   Crossref logo
Link1 Link2